| |
| |
| Introduction | |
| |
| |
| The Life and Times of the Human Major Histocompatibility Complex | |
| |
| |
| |
| Origins of Mhc Diversity | |
| |
| |
| |
| Genetics, Chemistry and Expression | |
| |
| |
| MHC Genes | |
| |
| |
| |
| Class I and Class II HLA Proteins and Genes: An Overview of Structure, Polymorphism, and Expression | |
| |
| |
| |
| Assembly and Intracellular Transport of MHC Molecules | |
| |
| |
| |
| Regulation and Deregulation of HLA Class II Genes | |
| |
| |
| |
| Minor Transplantation Antigens | |
| |
| |
| |
| Biological Function of MHC Molecules | |
| |
| |
| Biological Function of HLA Molecules | |
| |
| |
| |
| MHC Molecules in Thymic Development and Selection of the T Cell Repertoire | |
| |
| |
| |
| The Molecular Mechanisms of HLA Associated Autoimmunity | |
| |
| |
| |
| The Capacity of Class I MHC Molecules to Function as Signal Transduction Elements | |
| |
| |
| |
| The Major Histocompatibility Complex and Cell Physiology | |
| |
| |
| |
| MHC Control of Growth and Metastatic Properties of Tumor Cells | |
| |
| |
| |
| Allorecognition of HLA Molecules | |
| |
| |
| HLA Molecules in Allorecognition: T Cell Recognition and Typing Methods | |
| |
| |
| |
| B Cell Recognition and HLA Typing: Current Methods and Future Possibilities. Role of Alloantibodies and Monoclonal Antibodies as Reagents | |
| |
| |
| |
| HLA Antibodies, Non-HLA Antibodies, and Crossmatch Methods | |
| |
| |
| |
| Transplantation of the Alloimmunized Patient | |
| |
| |
| |
| HLA-Matching | |
| |
| |
| HLA Matching in Clinical Organ Transplantation | |
| |
| |
| |
| Transplantation Tolerance and Noninherited Maternal HLA Antigens | |
| |
| |
| |
| What To Do with the Immunized Patient. How to Avoid Humoral Immunization | |
| |
| |
| |
| Immunosuppression | |
| |
| |
| Immunosuppressive Therapy | |
| |
| |
| |
| Selective Depletion of Alloreactive Cells in Transplantation | |
| |
| |
| |
| Immunological Considerations on the Use of Monoclonal Antibodies for In Vitro and In Vivo Modification of Alloimmunity | |
| |
| |
| |
| Anti-idiotypic Antibodies in the HLA System | |
| |
| |
| |
| Rejection | |
| |
| |
| Cellular and Molecular Mechanism of Rejection and Role of Viral Infection | |
| |
| |
| |
| Fine-Needle Aspiration Biopsy in Rejection Diagnosis | |
| |
| |
| |
| Bone Marrow Transplantation | |
| |
| |
| Bone Marrow Transplantation Using Related Donors | |
| |
| |
| |
| Marrow Transplantation from Unrelated Donors | |
| |
| |
| |
| Purging of Bone Marrow | |
| |
| |
| |
| Xenografting | |
| |
| |
| Xenografting: Is It Feasible? | |
| |
| |
| |
| Malignancy after Transplantation | |
| |
| |
| Tumors in Transplanted Patients | |
| |
| |
| |
| Addendum | |
| |
| |
| Nomenclature for the Major Histocompatibility Complexes of Different Species: A Proposal | |
| |
| |
| |
| Revised Nomenclature of Mouse H-2 Genes | |
| |
| |
| |
| Subject Index | |